Anticholinergic drugs may increase risk of dementia
New research has suggested a link between taking anticholinergic medications and an increased risk of developing dementia. These drugs are old and are now rarely used for Parkinson’s.
Using patient data to plan better services and find a cure
Importance of using patent data to plan health and care services and find better treatments and introducing the new national data opt-out for England from 25 May, where patients can opt-out of having their confidential info shared with the NHS.
Artificial intelligence to help develop new Parkinson’s treatments
We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform’s capabilities to reason, deduce and suggest entirely new treatments for Parkinson’s.
Studying human brain tissue in 3D
An international team has developed a cutting-edge technique, enabling human brain tissue to be studied in 3D.
Investing in a new treatment to improve symptoms and slow Parkinson’s
Parkinson's UK is pleased to announce a new project worth £1.2million to fund essential research towards new treatment that could both improve symptoms and slow the progression of Parkinson's.
Calcium may play a role in Parkinson's
New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.
Investing in a new treatment for dyskinesia
We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.
Research into flu and the onset of Parkinson's
A study, featured in the Daily Mail, suggests a link between certain types of flu and risk of Parkinson's.
Pfizer pulls neuroscience projects
International pharmaceutical company, Pfizer, has announced a move to end all early-stage projects in neuroscience.
More than 12,000 Scots living with Parkinson's and numbers continue to rise
New figures from Parkinson's UK show that more than 12,000 Scots are now living with Parkinson's, and numbers are continuing to rise.